Altrova Health signs U.S. distribution deal, plans $500K placement

Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) has entered into an exclusive distribution agreement with Reliability Funding LLC, appointing the U.S.-based firm as its exclusive sales agent and distributor across the United States for its detection, protection, and wellness product portfolio, according to a company statement.

The agreement covers Altrova Health's current and future product lines, with the exception of the NIRLAB SA NIRLIGHT drug analysis device. Reliability Funding will be responsible for sales, business development, customer onboarding, and account management across retail, online, commercial, healthcare, and government channels. Altrova Health retains ownership of its brands, intellectual property, and supply functions. Compensation for Reliability Funding is structured as a share of profit generated on U.S. sales, with no minimum purchase commitments or guaranteed orders.

The agreement carries an initial two-year term with automatic renewal provisions tied to performance thresholds.

Concurrent with the announcement, Altrova Health disclosed a non-brokered private placement of up to US$500,000 to fund the U.S. commercial launch. Units will be priced at C$0.05 each, with each unit comprising one common share and one warrant exercisable at C$0.06 per share for three years from closing. The offering remains subject to approval from the Canadian Securities Exchange and other regulatory conditions, and may close in one or more tranches. All securities issued will be subject to a four-month-and-one-day statutory hold period.

Proceeds are intended for product procurement, initial inventory, customer onboarding, marketing and sales support, and general working capital.

"This agreement gives us a U.S. distribution platform for our detection, protection, and wellness products while we continue to do what we do best, build great products and stand behind our brands," said Geoff Benic, Chief Executive Officer of Altrova Health.

Altrova Health is a Canadian public company with a product portfolio that includes the ToxiShield fentanyl and drink-spiking detection line, the O-Spray product line, and the rapid detection strip portfolio of its subsidiary Drug Lab 118 Ltd.

You May Also Be Interested In

• Cognex (CGNX) Reiterated at Neutral by DA Davidson on Agreement to Acquire RealSense
• Weatherford International plc (WFRD) PT Lowered to $116 at UBS
• Ladybug Resource Group updates M&A program, holds early financing talks